Kent's CEO, Pierre Lemire, with SnapshotNIR

Kent Imaging's CEO, Pierre Lemire, interviewed for CEOCFO Magazine

CALGARY, AB, CANADA, July 7, 2022 /EINPresswire.com/ -- In a recent online interview published by CEOCFO Magazine, Kent Imaging’s CEO, Pierre Lemire, discusses their innovative flagship product, the portable wound imaging device, SnapshotNIR.

Kent’s near-infrared spectroscopy (NIRS) device is an actionable and low-risk option for patients, helping physicians gain greater patient compliance, save on time and costs, and easily integrate captured images into the patient record.

In the interview, Mr. Lemire explains that there is still much to learn and understand about wounds, including the complexities of the healing process and how these wounds respond to different treatments. Kent Imaging is developing tools and solutions that aid physicians with the clinical decision-making process which ultimately enhances patient care outcomes while decreasing healthcare costs.

“Changes to a wound can be subtle and often not visible with the eye. Diagnostic-driven tools like SnapshotNIR are extremely valuable in really understanding what is happening below the surface in the microvasculature network of the tissue,” states Mr. Lemire

Follow the link to read the entire interview https://tinyurl.com/597pn4n8

About Kent Imaging, Inc.
Kent Imaging, located in Calgary, Alberta, Canada, is a leading innovator in near-infrared tissue oxygenation imaging, which develops, manufactures, and markets medical technology that supports real-time decision-making in wound care, vascular and surgical subspecialties. Kent holds multiple patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. For more information about Kent Imaging, visit www.kentimaging.com

Leah Pavlick
Kent Imaging
+1 403-542-7314
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn